Spero Therapeutics, Inc. (SPRO)
2.635
-0.10
(-3.83%)
USD |
NASDAQ |
Jun 09, 13:56
Spero Therapeutics Market Cap : 152.54M for June 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Inovio Pharmaceuticals, Inc. | 77.45M |
| SELLAS Life Sciences Group, Inc. | 1.385B |
| ACADIA Pharmaceuticals, Inc. | 3.723B |
| Alnylam Pharmaceuticals, Inc. | 39.82B |
| Savara, Inc. | 999.00M |
Market Cap Related Metrics
| PE Ratio | 10.82 |
| PS Ratio | 2.754 |
| Price to Book Value | 2.882 |
| Price to Free Cash Flow | 20.83 |
| Price | 2.635 |
| Earnings Yield | 9.24% |
| Operating PE Ratio | 19.44 |
| Normalized PE Ratio | 10.46 |